These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37693774)

  • 21. Development of a read-across workflow for skin irritation and corrosion predictions.
    Abe A; Sezaki T; Kinoshita K
    SAR QSAR Environ Res; 2019 Apr; 30(4):279-298. PubMed ID: 31012352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring current read-across applications and needs among selected U.S. Federal Agencies.
    Patlewicz G; Lizarraga LE; Rua D; Allen DG; Daniel AB; Fitzpatrick SC; Garcia-Reyero N; Gordon J; Hakkinen P; Howard AS; Karmaus A; Matheson J; Mumtaz M; Richarz AN; Ruiz P; Scarano L; Yamada T; Kleinstreuer N
    Regul Toxicol Pharmacol; 2019 Aug; 106():197-209. PubMed ID: 31078681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Building scientific confidence in the development and evaluation of read-across.
    Patlewicz G; Ball N; Boogaard PJ; Becker RA; Hubesch B
    Regul Toxicol Pharmacol; 2015 Jun; 72(1):117-33. PubMed ID: 25857293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring conceptual and theoretical frameworks for nurse practitioner education: a scoping review protocol.
    Wilson R; Godfrey CM; Sears K; Medves J; Ross-White A; Lambert N
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):146-55. PubMed ID: 26571290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic evaluation of analogs and automated read-across prediction of estrogenicity: A case study using hindered phenols.
    Pradeep P; Mansouri K; Patlewicz G; Judson R
    Comput Toxicol; 2017 Nov; 4():22-30. PubMed ID: 30057968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolomics as read-across tool: An example with 3-aminopropanol and 2-aminoethanol.
    Sperber S; Wahl M; Berger F; Kamp H; Lemke O; Starck V; Walk T; Spitzer M; Ravenzwaay BV
    Regul Toxicol Pharmacol; 2019 Nov; 108():104442. PubMed ID: 31421187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Read-across approaches--misconceptions, promises and challenges ahead.
    Patlewicz G; Ball N; Becker RA; Booth ED; Cronin MT; Kroese D; Steup D; van Ravenzwaay B; Hartung T
    ALTEX; 2014; 31(4):387-96. PubMed ID: 25368965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supporting read-across using biological data.
    Zhu H; Bouhifd M; Donley E; Egnash L; Kleinstreuer N; Kroese ED; Liu Z; Luechtefeld T; Palmer J; Pamies D; Shen J; Strauss V; Wu S; Hartung T
    ALTEX; 2016; 33(2):167-82. PubMed ID: 26863516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lessons learned from read-across case studies for repeated-dose toxicity.
    Schultz TW; Cronin MTD
    Regul Toxicol Pharmacol; 2017 Aug; 88():185-191. PubMed ID: 28655656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of category approaches, read-across and (Q)SAR: general considerations.
    Patlewicz G; Ball N; Booth ED; Hulzebos E; Zvinavashe E; Hennes C
    Regul Toxicol Pharmacol; 2013 Oct; 67(1):1-12. PubMed ID: 23764304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
    Sinclair P; Kable A; Levett-Jones T
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advancing the science of a read-across framework for evaluation of data-poor chemicals incorporating systematic and new approach methods.
    Lizarraga LE; Suter GW; Lambert JC; Patlewicz G; Zhao JQ; Dean JL; Kaiser P
    Regul Toxicol Pharmacol; 2023 Jan; 137():105293. PubMed ID: 36414101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Filling Data Gaps by Read-across: A Mini Review on its Application, Developments and Challenges.
    Kovarich S; Ceriani L; Fuart Gatnik M; Bassan A; Pavan M
    Mol Inform; 2019 Aug; 38(8-9):e1800121. PubMed ID: 30977298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NAM-supported read-across: From case studies to regulatory guidance in safety assessment.
    Rovida C; Escher SE; Herzler M; Bennekou SH; Kamp H; Kroese DE; Maslankiewicz L; Moné MJ; Patlewicz G; Sipes N; Van Aerts L; White A; Yamada T; Van de Water B
    ALTEX; 2021; 38(1):140-150. PubMed ID: 33452529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantifying Analogue Suitability for SAR-Based Read-Across Toxicological Assessment.
    Lester C; Byrd E; Shobair M; Yan G
    Chem Res Toxicol; 2023 Feb; 36(2):230-242. PubMed ID: 36701522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sourcing data on chemical properties and hazard data from the US-EPA CompTox Chemicals Dashboard: A practical guide for human risk assessment.
    Williams AJ; Lambert JC; Thayer K; Dorne JCM
    Environ Int; 2021 Sep; 154():106566. PubMed ID: 33934018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Grouping MWCNTs based on their similar potential to cause pulmonary hazard after inhalation: a case-study.
    Murphy F; Jacobsen NR; Di Ianni E; Johnston H; Braakhuis H; Peijnenburg W; Oomen A; Fernandes T; Stone V
    Part Fibre Toxicol; 2022 Jul; 19(1):50. PubMed ID: 35854357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Read-across predictions of nanoparticle hazard endpoints: a mathematical optimization approach.
    Varsou DD; Afantitis A; Melagraki G; Sarimveis H
    Nanoscale Adv; 2019 Sep; 1(9):3485-3498. PubMed ID: 36133569
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.